This inventor holds 1 USPTO granted patent. Top assignee: Enobia Pharma Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Gethin Thomas: Innovator in Osteogenesis
Introduction
Gethin Thomas is a notable inventor based in St. Albans, GB. He has made significant contributions to the field of biomedical research, particularly in the area of osteogenesis. His innovative work has led to the development of a unique method that utilizes specific natriuretic peptide receptor c ligands.
Latest Patents
Gethin Thomas holds 1 patent for his invention titled "Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof." This patent describes a method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative to increase osteogenesis in mammals. The method involves administering a therapeutically effective amount of the Ostn or NPR-C specific Ostn peptide derivative to the mammal.
Career Highlights
Gethin Thomas is currently associated with Enobia Pharma Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for enhancing bone formation and addressing related medical conditions.
Collaborations
Gethin has collaborated with esteemed colleagues such as Christian Lanctot and Pierre Moffatt, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Gethin Thomas exemplifies the spirit of innovation in the field of osteogenesis through his groundbreaking patent and collaborative efforts. His contributions are paving the way for future advancements in biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile